Department of Neurosciences, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia.
Department of Neurosciences, School of Medical Sciences, Universiti Sains Malaysia; Center for Neuroscience Services and Research, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia.
J Cancer Res Ther. 2020 Oct-Dec;16(6):1517-1521. doi: 10.4103/jcrt.JCRT_1132_16.
Meningiomas are among the most common intracranial tumors of the central nervous system. It is widely accepted that the initiation and progression of meningiomas involve the accumulation of nucleus genetic alterations, but little is known about the implication of mitochondrial genomic alterations during development of these tumors. The human mitochondrial DNA (mtDNA) contains a short hypervariable, noncoding displacement loop control region known as the D-Loop. Alterations in the mtDNA D-loop have been reported to occur in most types of human cancers. The purpose of this study was to assess the mtDNA D-loop mutations in Malaysian meningioma patients.
Genomic DNA was extracted from 21 fresh-frozen tumor tissues and blood samples of the same meningioma patients. The entire mtDNA D-loop region (positions 16024-576) was polymerase chain reaction amplified using designed primers, and then amplification products were purified before the direct DNA sequencing proceeds.
Overall, 10 (47.6%) patients were detected to harbor a total of 27 somatic mtDNA D-loop mutations. Most of these mtDNA mutations were identified in the hypervariable segment II (40.7%), with 33.3% being located mainly in the conserved sequence block II of the D310 sequence. Furthermore, 58 different germline variations were observed at 21 nucleotide positions.
Our results suggest that mtDNA alterations in the D-loop region may be an important and early event in developing meningioma. Further studies are needed, including validation in a larger patient cohort, to verify the clinicopathological outcomes of mtDNA mutation biomarkers in meningiomas.
脑膜瘤是中枢神经系统最常见的颅内肿瘤之一。人们普遍认为脑膜瘤的发生和发展涉及核基因突变的积累,但对于这些肿瘤发生过程中线粒体基因组改变的意义知之甚少。人类线粒体 DNA(mtDNA)含有一个短的高度可变、非编码的置换环控制区,称为 D 环。已经报道 mtDNA D 环的改变发生在大多数类型的人类癌症中。本研究旨在评估马来西亚脑膜瘤患者 mtDNA D 环突变。
从 21 例脑膜瘤患者的新鲜冷冻肿瘤组织和血液样本中提取基因组 DNA。使用设计的引物对整个 mtDNA D 环区域(位置 16024-576)进行聚合酶链反应扩增,然后在直接 DNA 测序之前对扩增产物进行纯化。
总体而言,10 例(47.6%)患者共检测到 27 个体细胞 mtDNA D 环突变。这些 mtDNA 突变大多数发生在高度可变区 II(40.7%),其中 33.3%主要位于 D310 序列的保守序列块 II。此外,在 21 个核苷酸位置观察到 58 种不同的种系变异。
我们的研究结果表明,D 环区 mtDNA 的改变可能是脑膜瘤发生的一个重要和早期事件。需要进一步研究,包括在更大的患者队列中进行验证,以验证 mtDNA 突变生物标志物在脑膜瘤中的临床病理结果。